Abstract:There has been a long-standing controversy regarding the number of lymph nodes (LNs) examined intraoperatively for accurate lymphatic staging and significantly better survival of patients with pancreatic ductal adenocarcinoma (PDAC), and no consensus has been reached for the elderly with the age of over 75 years. Given these, the present study aims to investigate the appropriate number of examined lymph nodes (ELNs) for elderly patients mentioned above. In this study, population-based data on 20,125 patients in 2000 to 2019 from the Surveillance, Epidemiology, and End Results database were reviewed retrospectively. The eighth edition staging system of the American Joint Committee on Cancer (AJCC) was applied. Propensity score matching (PSM) was performed to reduce the effects of multiple biases. By using binomial probability law and maximally selected rank statistics, the minimum number of ELN (MNELN) for accurate nodal involvement assessment and optimal ELN number for significantly better survival were calculated, respectively. In addition, Kaplan-Meier curves and Cox proportional hazard regression models were constructed for further survival analysis. As a result, 6623 patients were enrolled in total in the study. Elderly patients had fewer lymph node metastases and a smaller lymph node ratio (LNR) (all P<0.05). However, poorer overall survival (OS) and cancer-specific survival (CSS) of elderly patients were observed in each pN stage (all P<0.05), except for CSS in N2. The proportions of N2 and N0 stages increased and decreased respectively with increasing number of ELN significantly. MNELN for accurate nodal assessment was 19 according to binomial probability law, and the optimal ELN number for significantly better survival was 17. Additionally, the number of ELN (<17 or ≥17) was also considered a strong prognostic predictor for elderly PDAC patients (≥75 years) in the Cox proportional hazard regression model (Overall survival: hazard ratio [HR]=0.74, 95% confidence interval [CI]: 0.65-0.83, P<0.001; Cancer-specific survival: HR=0.75, 95% CI: 0.66-0.85, P<0.001). In conclusion, extended lymphadenectomy is suitable for elderly PDAC patients undergoing curative-intent surgery owing to an accurate assessment of nodal status and improved long-term prognosis. However, a random, prospective clinical trial is warranted before the recommendation of extended lymphadenectomy for the elderly.

A Novel Criterion for Lymph Nodes Dissection in Distal Pancreatectomy for Ductal Adenocarcinoma: A Population Study of the US SEER Database

The Relationship Between the Number of Examined Lymph Nodes and the Efficacy of Chemotherapy for Gastric Cancer

Impact of examined lymph node count on prognosis in patients with lymph node-negative pancreatic body/tail ductal adenocarcinoma.

Proposal Of The Optimal Numbers Of Examined And Positive Lymph Nodes To The 8th Edition Of American Joint Committee On Cancer (Ajcc) Staging For 758 Patients With Distal Cholangiocarcinoma

Significance of Examined Lymph Node Number in Accurate Staging and Long-Term Survival in Resected Stage I-II Pancreatic Cancer: More is Better? A Large International Population-Based Cohort Study.

Lymph node examination and survival in resected pancreatic ductal adenocarcinoma: retrospective study

Defining the Minimal and Optimal Thresholds for Lymph Node Resection and Examination for Intraductal Papillary Mucinous Neoplasm Derived Pancreatic Cancer

Association Between Lymph Node Examination and Nodal Staging for Pancreatic Adenocarcinoma: A Population-Based Analysis.

Number of Positive Lymph Nodes is Superior to LNR and LODDS for Predicting the Prognosis of Pancreatic Neuroendocrine Neoplasms

Determining the Optimal Number of Examined Lymph Nodes for Accurate Staging of Pancreatic Cancer: an Analysis Using the Nodal Staging Score Model.

Role of Lymph Node Resection and Histopathological Evaluation in Accurate Staging of Nonfunctional Pancreatic Neuroendocrine Tumors: How Many Are Enough?

Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non-Small-Cell Lung Cancer: A Population Study of the Us Seer Database and A Chinese Multi-Institutional Registry

The Extent of Mediastinal Lymph Node Dissection Correlates with Survival of Small Cell Lung Cancer Patients after Resection: a Propensity Score-Matched Cohort Study Analysis.

Prognostic Value of Lymph Node Positivity and Number of Lymph Nodes Required for Accurate Staging of Pancreatic Neuroendocrine Tumors.

Exploration of the Lymphadenectomy Strategy for Elderly Pancreatic Ductal Adenocarcinoma Patients Undergoing Curative-Intent Resection.

A Large Real-World Cohort Study of Examined Lymph Node Standards for Adequate Nodal Staging in Early Non-Small Cell Lung Cancer.

Prognostic Importance of Numbers of Retrieved Lymph Nodes and Positive Lymph Nodes for Ampulla of Vater Cancer (AVC) in 2347 Patients from the Surveillance, Epidemiology, and End Results (SEER) Database.

Prognostic Impact of Lymphadenectomy on Outcomes of Sublobar Resection for Stage IA Non–small Cell Lung Cancer ≤2 Cm

Pathologically Examining a Minimum of Three Lymph Nodes Could Better Determine Node Negativity in Patients with Non-Metastatic Chromophobe Renal Cell Carcinoma

Extent of Lymph Node Retrieval and Pancreatic Cancer Survival: Information from a Large US Population Database

Impact of examined lymph node count on survival outcomes in patients with stage T1-2N0M0 small cell lung cancer undergoing surgery: A retrospective cohort study